Common blood pressure medicine blocks molecule that can trigger the disease
A drug commonly used to control high blood pressure may also help prevent the onset of Type 1 diabetes in up to 60 percent of those at risk for the disease, according to researchers at the University of Colorado Anschutz Medical Campus and the University of Florida (UF) in Gainesville.
The study was published online this week in the Journal of Clinical Investigation.
“This is the first personalized treatment for Type 1 diabetes prevention,” said Aaron Michels, MD, a researcher at the Barbara Davis Center for Childhood Diabetes and associate professor of medicine at CU Anschutz. “We made this discovery using a supercomputer, on the lab bench, in mice and in humans.”
The drug, methyldopa, has been used for over 50 years to treat high blood pressure in pregnant women and children. It is on the World Health Organization’s list of essential drugs.
But like many drugs used for one condition, Michels and his colleagues found it useful for something totally unrelated.
Some 60 percent of people at risk of getting Type 1 diabetes possess the DQ8 molecule which significantly increases the chance of getting the disease. The researchers believed that if they could block specifically the DQ8 molecule they could also block the onset of the disease.
“All drugs have off-target effects. If you take too much acetaminophen you can hurt your liver,” Michels said. “We took every FDA-approved small molecule drug and analyzed HLA-DQ8 binding through a supercomputer. We searched a thousand orientations for each drug to identify those that would fit within the DQ8 molecule binding groove.”
After running thousands of drugs through the supercomputer, they found that methyldopa not only blocked DQ8, but it didn’t harm the immune function of other cells like many immunosuppressant drugs do.
The research spanned 10 years and its efficacy was shown in mice and in 20 Type 1 diabetes patients who took part in a clinical trial at the Barbara Davis Center at the University of Colorado School of Medicine.
“We can now predict with almost 100 percent accuracy who is likely to get Type 1 diabetes,” Michels said. “The goal with this drug is to delay or prevent the onset of the disease among those at risk.”
The drug is taken orally, three times a day.
Implications for treatment
Michels and UF Health researcher David Ostrov, PhD, hope this same approach of blocking specific molecules can be used in other diseases.
“This study has significant implications for treatment of diabetes and also other autoimmune diseases,” said Ostrov, associate professor of pathology, immunology and laboratory medicine in the UF College of Medicine and a member of the UF Health Cancer Center, Genetics Institute and Center for NeuroGenetics. “This study suggests that the same approach may be adapted to prevent autoimmune diseases such as rheumatoid arthritis, coeliac disease, multiple sclerosis, systemic lupus erythematosus and others.”
The next step will be a larger clinical trial sponsored by the National Institutes of Health in spring.
“With this drug, we can potentially prevent up to 60 percent of Type 1 diabetes in those at risk for the disease,” Michels said. “This is very significant development.”
The Latest on: Type 1 diabetes
via Google News
The Latest on: Type 1 diabetes
- 92-year-old cyclist was diagnosed with type 1 diabetes 50 years ago. Now, he cycles for a cure.on October 15, 2019 at 6:19 pm
92-year-old cyclist was diagnosed with type 1 diabetes 50 years ago. Now, he cycles for a cure. John "Jack" Hughes, 92, is going to Death Valley, California to cycle in the JDRF Ride to Cure Diabetes.
- Prevalence of Dental Caries in Children and Adolescents With Type 1 Diabeteson October 15, 2019 at 10:47 am
Background: Dental caries and type 1 diabetes are responsible for a large burden of global disease; however, the exact prevalence of dental caries among children and adolescents with type 1 diabetes ...
- Rotavirus plays role in development of type 1 diabeteson October 13, 2019 at 2:21 pm
A new article published in the journal PLOS Pathogens on October 10, 2019, claims that the common rotavirus may be responsible for some occurrences of type 1 diabetes, a form of diabetes which occurs ...
- How Brexit Could Mean 7 Days Between Life and Death With Type 1 Diabeteson October 11, 2019 at 5:29 pm
Every single person on the planet needs insulin to stay alive. Most people don’t have to give this a single thought, but if you’re like me and have type 1 diabetes, we have to think about insulin ...
- Rotavirus infection may turn on type 1 diabeteson October 10, 2019 at 1:12 pm
Rotavirus infection may play a role in the development of type 1 diabetes, according to a front matter article published October 10 in the open-access journal PLOS Pathogens by Leonard C. Harrison of ...
- More benefits to vaccination: rotavirus vaccines reduce the incidence of type-1 diabeteson October 10, 2019 at 12:11 pm
Kaitlin A. Davis and Andrew Mehle discuss the research and context behind the new PLOS Pathogens Pearls article, “Does rotavirus turn on type 1 diabetes?”. There is a growing appreciation that viral ...
- Establishment of a diabetes mellitus type 1 model in the common marmoseton October 10, 2019 at 2:25 am
Accordingly, in this study, we investigated whether the combination of partial pancreatectomy and STZ administration could successfully and safely induce diabetes mellitus type 1 in the common ...
- ImmunoMolecular Therapeutics Nabs $10 Million for Type 1 Diabetes Treatmenton October 9, 2019 at 5:58 pm
ImmunoMolecular Therapeutics Inc. has raised $10 million to develop drugs that stop the progression of Type 1 diabetes and other autoimmune diseases. Biotech companies are seeking new treatments for ...
- Thousands of cyclists come together to find a cure for type 1 diabetes at Yonge-Dundas Squareon October 9, 2019 at 5:02 pm
TORONTO, Oct. 09, 2019 (GLOBE NEWSWIRE) -- The Sun Life Ride to Defeat Diabetes for JDRF is a corporate stationary cycling event that will see over 12,000 Canadians come together in cities across ...
via Bing News